Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by pathogenic variants in sarcomeric genes, leading to left ventricular hypertrophy and complex phenotypic heterogeneity. While HCM is the most common inherited cardiomyopathy, pharmacological treatment options have previously been limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Packard, Elizabeth, de Feria, Alejandro, Peshin, Supriya, Reza, Nosheen, Owens, Anjali Tiku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652179/
https://www.ncbi.nlm.nih.gov/pubmed/36243823
http://dx.doi.org/10.1007/s40119-022-00283-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652179/
https://www.ncbi.nlm.nih.gov/pubmed/36243823
http://dx.doi.org/10.1007/s40119-022-00283-5

Ejemplares similares